Company: RGNT
Filing Date: 2025-09-30
Form Type: F-1/A
Source: 0001213900-25-093302
Chunk: 42

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-09-30
Form: F-1/A
Chunk 42
---
 non-payment of fees and failure to properly legalize and submit formal
documents. If we fail to maintain the patents and patent applications covering our products, we may not be able to stop a competitor
from marketing products that are the same as or similar to our products, which would have a material adverse effect on our business.

Although we are not presently a party to lawsuits or administrative proceedings involving patents or other intellectual property, the possibility exists that we may be in the future. If we were to lose any future intellectual property lawsuits, a court could require us to pay significant damages and/or prevent us from selling our products.

Although we are not presently
a party to lawsuits or administrative proceedings involving patents or other intellectual property, including interference proceedings,
post grant review and inter partesreview before the USPTO or the equivalent foreign patent authority, the possibility exists
that we may be in the future. A legal proceeding, regardless of the outcome, could drain our financial resources and divert the time
and effort of our management. Protracted litigation to defend or prosecute our intellectual property rights could result in our customers
or potential customers deferring or limiting their purchase or use of the affected products until resolution of the litigation.

<div align='center'>31</div>

If we are found to infringe
a third party’s intellectual property rights, we could be required to obtain a license from such third party to continue selling,
developing and marketing our products and techniques. However, we may not be able to obtain any required license on commercially reasonable
terms or at all. Even if we were able to obtain a license, it could be non-exclusive, thereby giving our competitors access to the same
technologies licensed to us. We could be forced, including by court order, to cease commercializing the infringing technology or product.
In addition, we could be found liable for monetary damages, including treble damages and attorneys’ fees if we are found to have
willfully infringed a patent. A finding of infringement could force us to cease some of our business operations, which could materially
harm our business. Claims that we have misappropriated the confidential information or trade secrets of third parties could have a similar
negative impact on our business. Intellectual property litigation may lead to unfavorable publicity that harms our reputation and causes
the market price of our Ordinary Shares to decline.

Because competition in our
industry is intense, competitors may infringe or otherwise violate our issued patents, patents of our licensors or other intellectual
property. To counter infringement or unauthorized use, we